The IFN-mediated increase in PD-L1 expression represents a form of “adaptive resistance” [51], which we demonstrated in our results with an upregulation of IFN and PD-L1 in cells with high TMPRSS2 expression and in COVID-19 patients. Here, TMPRSS2 is linked to COVID-19.